Workout
Healthy Eating
Meditation
Podcast
Authenticity
Social Service
About Us
Review Board
Editorial Process
Contact Us
Health Tracker
AI Tools
✔Fact Checked

The RFEF denies having sent a report to Barcelona on the signings of Dani Olmo and Pau Víctor

The information war over the signings of Dani Olmo and Pau Víctor at Barcelona continues, with contradictory information emerging in this regard on Monday. The Blaugrana have maintained their “confidence” that both players will be registered in each phase, but so far that has not been enough.

On Monday it was learned that the RFEF had recognized in a report sent to Barcelona that the rules are not appropriate for the cases of Olmo and Víctor. The Catalan giants were apparently intending to use this information in court, and the Federation is apparently considering a change to the rules in the coming months.

However, Marca has since denied that this is the case. Their information, as stated by RFEF sources, is that no report of that type has been issued and nothing suggests that the Ministry of Sports (CSD), to which Barcelona will turn on Tuesday, sees their case differently than like the RFEF or La Liga. They also note that the case is unlikely to be resolved before 10 days pass, meaning Olmo and Víctor will at least miss the Spanish Super Cup in Saudi Arabia. They do say that the RFEF is studying the modification of the regulations and legislative changes, but in general more than related to this case, and no information has been issued subsequently.

Last reviewed on

Expert Q&A

Ask a Question
Share Now:

Was this article helpful?

🤓

😕

dotdash removebg preview

FitToFar is part of the Dotdash Meredith publishing family.

Please review our updated Terms of Service.

BE THE FIRST TO KNOW

SUBSCRIBE TO GET LATEST FITNESS AND NUTRITION UPDATES!

We don’t spam! Read our privacy policy for more info.

The FitToFar News team takes pride in providing readers with accurate, properly sourced, and objectively analyzed content. Each news piece is stringently fact-checked by our Integrity Network, and any form of plagiarism or malicious behavior from our authors and contributors is strictly forbidden.

Our articles follow a number of key standards:

  • Each cited research and studies should come from renowned peer-reviewed journals or educational bodies. Additionally, any quoted data and figures must be traceable to its origin, while also detailing their significance.

  • Content related to treatment, medicine, and procedure must plainly specify availability, cost, possible side effects, targets, possible interactions, and unapproved usage (if relevant).

  • Every news article should have inputs from at least two authorized professionals, with corresponding qualifications and ties to appropriate associations or works.

  • The reader must be made aware of any potential conflict of interest relating to the source or study.

  • Finally, all news pieces should be supplied with enough background and context regarding the relevant topic or condition.